Cargando…

Poliovirus seroprevalence before and after interruption of poliovirus transmission in Kano State, Nigeria

INTRODUCTION: In September 2015, Nigeria was removed from the list of polio-endemic countries after more than 12 months had passed since the detection of last wild poliovirus case in the country on 24 July 2014. We are presenting here a report of two polio seroprevalence surveys conducted in Septemb...

Descripción completa

Detalles Bibliográficos
Autores principales: Iliyasu, Zubairu, Verma, Harish, Craig, Kehinde T., Nwaze, Eric, Ahmad-Shehu, Amina, Jibir, Binta Wudil, Gwarzo, Garba Dayyabu, Gajida, Auwalu U., Weldon, William C., Steven Oberste, M., Takane, Marina, Mkanda, Pascal, Muhammad, Ado J.G., Sutter, Roland W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5036508/
https://www.ncbi.nlm.nih.gov/pubmed/27591950
http://dx.doi.org/10.1016/j.vaccine.2016.08.058
_version_ 1782455569372676096
author Iliyasu, Zubairu
Verma, Harish
Craig, Kehinde T.
Nwaze, Eric
Ahmad-Shehu, Amina
Jibir, Binta Wudil
Gwarzo, Garba Dayyabu
Gajida, Auwalu U.
Weldon, William C.
Steven Oberste, M.
Takane, Marina
Mkanda, Pascal
Muhammad, Ado J.G.
Sutter, Roland W.
author_facet Iliyasu, Zubairu
Verma, Harish
Craig, Kehinde T.
Nwaze, Eric
Ahmad-Shehu, Amina
Jibir, Binta Wudil
Gwarzo, Garba Dayyabu
Gajida, Auwalu U.
Weldon, William C.
Steven Oberste, M.
Takane, Marina
Mkanda, Pascal
Muhammad, Ado J.G.
Sutter, Roland W.
author_sort Iliyasu, Zubairu
collection PubMed
description INTRODUCTION: In September 2015, Nigeria was removed from the list of polio-endemic countries after more than 12 months had passed since the detection of last wild poliovirus case in the country on 24 July 2014. We are presenting here a report of two polio seroprevalence surveys conducted in September 2013 and October 2014, respectively, in the Kano state of northern Nigeria. METHODS: Health facility based seroprevalence surveys were undertaken at Murtala Mohammad Specialist Hospital, Kano. Parents or guardians of children aged 6–9 months, 36–47 months, 5–9 years and 10–14 years in 2013 and 6–9 months and 19–22 months (corresponding to 6–9 months range at the time of 2013 survey) in 2014 presenting to the outpatient department, were approached for participation, screened for eligibility and asked to provide informed consent. A questionnaire was administered and a blood sample collected for polio neutralization assay. RESULTS: Among subjects aged 6–9 months in the 2013 survey, seroprevalence was 58% (95% confidence interval [CI] 51–66%) to poliovirus type 1, 42% (95% CI 34–50%) to poliovirus type 2, and 52% (95% CI 44–60%) to poliovirus type 3. Among children 36–47 months and older, seroprevalence was 85% or higher for all three serotypes. In 2014, seroprevalence in 6–9 month infants was 72% (95% CI 65–79%) for type 1, 59% (95% CI 52–66%) for type 2, and 65% (95% CI 57–72%) for type 3 and in 19–22 months, 80% (95% CI 74–85%), 57% (49–63%) and 78% (71–83%) respectively. Seroprevalence was positively associated with history of increasing oral poliovirus vaccine doses. CONCLUSIONS: There was significant improvement in seroprevalence in 2014 over the 2013 levels indicating a positive impact of recent programmatic interventions. However the continued low seroprevalence in 6–9 month age is a concern and calls for improved immunization efforts to sustain the polio-free Nigeria.
format Online
Article
Text
id pubmed-5036508
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Elsevier Science
record_format MEDLINE/PubMed
spelling pubmed-50365082016-09-30 Poliovirus seroprevalence before and after interruption of poliovirus transmission in Kano State, Nigeria Iliyasu, Zubairu Verma, Harish Craig, Kehinde T. Nwaze, Eric Ahmad-Shehu, Amina Jibir, Binta Wudil Gwarzo, Garba Dayyabu Gajida, Auwalu U. Weldon, William C. Steven Oberste, M. Takane, Marina Mkanda, Pascal Muhammad, Ado J.G. Sutter, Roland W. Vaccine Article INTRODUCTION: In September 2015, Nigeria was removed from the list of polio-endemic countries after more than 12 months had passed since the detection of last wild poliovirus case in the country on 24 July 2014. We are presenting here a report of two polio seroprevalence surveys conducted in September 2013 and October 2014, respectively, in the Kano state of northern Nigeria. METHODS: Health facility based seroprevalence surveys were undertaken at Murtala Mohammad Specialist Hospital, Kano. Parents or guardians of children aged 6–9 months, 36–47 months, 5–9 years and 10–14 years in 2013 and 6–9 months and 19–22 months (corresponding to 6–9 months range at the time of 2013 survey) in 2014 presenting to the outpatient department, were approached for participation, screened for eligibility and asked to provide informed consent. A questionnaire was administered and a blood sample collected for polio neutralization assay. RESULTS: Among subjects aged 6–9 months in the 2013 survey, seroprevalence was 58% (95% confidence interval [CI] 51–66%) to poliovirus type 1, 42% (95% CI 34–50%) to poliovirus type 2, and 52% (95% CI 44–60%) to poliovirus type 3. Among children 36–47 months and older, seroprevalence was 85% or higher for all three serotypes. In 2014, seroprevalence in 6–9 month infants was 72% (95% CI 65–79%) for type 1, 59% (95% CI 52–66%) for type 2, and 65% (95% CI 57–72%) for type 3 and in 19–22 months, 80% (95% CI 74–85%), 57% (49–63%) and 78% (71–83%) respectively. Seroprevalence was positively associated with history of increasing oral poliovirus vaccine doses. CONCLUSIONS: There was significant improvement in seroprevalence in 2014 over the 2013 levels indicating a positive impact of recent programmatic interventions. However the continued low seroprevalence in 6–9 month age is a concern and calls for improved immunization efforts to sustain the polio-free Nigeria. Elsevier Science 2016-09-30 /pmc/articles/PMC5036508/ /pubmed/27591950 http://dx.doi.org/10.1016/j.vaccine.2016.08.058 Text en © 2016 The Authors. Published by Elsevier Ltd. http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Iliyasu, Zubairu
Verma, Harish
Craig, Kehinde T.
Nwaze, Eric
Ahmad-Shehu, Amina
Jibir, Binta Wudil
Gwarzo, Garba Dayyabu
Gajida, Auwalu U.
Weldon, William C.
Steven Oberste, M.
Takane, Marina
Mkanda, Pascal
Muhammad, Ado J.G.
Sutter, Roland W.
Poliovirus seroprevalence before and after interruption of poliovirus transmission in Kano State, Nigeria
title Poliovirus seroprevalence before and after interruption of poliovirus transmission in Kano State, Nigeria
title_full Poliovirus seroprevalence before and after interruption of poliovirus transmission in Kano State, Nigeria
title_fullStr Poliovirus seroprevalence before and after interruption of poliovirus transmission in Kano State, Nigeria
title_full_unstemmed Poliovirus seroprevalence before and after interruption of poliovirus transmission in Kano State, Nigeria
title_short Poliovirus seroprevalence before and after interruption of poliovirus transmission in Kano State, Nigeria
title_sort poliovirus seroprevalence before and after interruption of poliovirus transmission in kano state, nigeria
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5036508/
https://www.ncbi.nlm.nih.gov/pubmed/27591950
http://dx.doi.org/10.1016/j.vaccine.2016.08.058
work_keys_str_mv AT iliyasuzubairu poliovirusseroprevalencebeforeandafterinterruptionofpoliovirustransmissioninkanostatenigeria
AT vermaharish poliovirusseroprevalencebeforeandafterinterruptionofpoliovirustransmissioninkanostatenigeria
AT craigkehindet poliovirusseroprevalencebeforeandafterinterruptionofpoliovirustransmissioninkanostatenigeria
AT nwazeeric poliovirusseroprevalencebeforeandafterinterruptionofpoliovirustransmissioninkanostatenigeria
AT ahmadshehuamina poliovirusseroprevalencebeforeandafterinterruptionofpoliovirustransmissioninkanostatenigeria
AT jibirbintawudil poliovirusseroprevalencebeforeandafterinterruptionofpoliovirustransmissioninkanostatenigeria
AT gwarzogarbadayyabu poliovirusseroprevalencebeforeandafterinterruptionofpoliovirustransmissioninkanostatenigeria
AT gajidaauwaluu poliovirusseroprevalencebeforeandafterinterruptionofpoliovirustransmissioninkanostatenigeria
AT weldonwilliamc poliovirusseroprevalencebeforeandafterinterruptionofpoliovirustransmissioninkanostatenigeria
AT stevenoberstem poliovirusseroprevalencebeforeandafterinterruptionofpoliovirustransmissioninkanostatenigeria
AT takanemarina poliovirusseroprevalencebeforeandafterinterruptionofpoliovirustransmissioninkanostatenigeria
AT mkandapascal poliovirusseroprevalencebeforeandafterinterruptionofpoliovirustransmissioninkanostatenigeria
AT muhammadadojg poliovirusseroprevalencebeforeandafterinterruptionofpoliovirustransmissioninkanostatenigeria
AT sutterrolandw poliovirusseroprevalencebeforeandafterinterruptionofpoliovirustransmissioninkanostatenigeria